Archbow Consulting’s Post

Aayuntra Metamorphosis! 🧬💊⚕️ We are thrilled to announce the launch of Aayuntra, a cutting-edge life science technology company! Our mission is simple yet profound: to empower life science companies by providing tailored solutions deeply rooted in strategy, science, technology, and business. At Aayuntra, we partner with companies that are solving the most complex challenges in healthcare. Together, we are paving the way for a healthier, more sustainable future for humankind. 🌟 Whether it's bespoke drug delivery systems, digital health solutions, or advanced manufacturing, we’re here to turn the boldest visions into reality. Join us on this journey as we redefine the future of life science technology. #LifeScience #Technology #Innovation #Sustainability #Healthcare #Aayuntra #Pharma #Biotechnology #MedTech #CombinationProduct #medicaldevice #diagnosticdevice #PDA #FDA #PODD #drugdelivery #Pharmaceuticals #manufacturing #CQV #validation #fillfinish #packaging #digialhealth

NEW PHARMA PRODUCT LAUNCH ALERT: New #biopharma products are launching every day, but payers are increasingly reluctant to cover their costs. Sound familiar? Whether you’re a startup or a Fortune 500, if you are facing this challenge then you should attend this panel discussion at #Asembia24, “Optimizing Market Access and Commercialization for New Biotech Product Launches.” Who: Dina Steinfurth, Cora Meese, MBA, Kevin Cast, Andrew Udell When: 2 pm ET, April 30 Where: Asembia's AXS24 Summit 👇 👇 👇 #marketaccess

Can the drug development industry change for the better? In a short documentary for the 2024 Global Health Summit, we tackle that question head-on. Dive into the obstacles and inefficiencies of the traditional outsourcing paradigm, and how Altasciences has broken from tradition to offer an alternative that can help you bring better drugs to the people who need them, faster. Watch the full video on Reuters: https://lnkd.in/dTsdaHmX #DrugDevelopment #Biopharma #Biotech

In FY23, the overall Indian healthcare market was around $180 billion with healthcare innovation accounting for $30 billion, or 15% of the market. While the healthcare innovation market is largely dominated by pharma services and health tech, biotech, and medtech are also some of the emerging areas that show promise. Read more here -https://bit.ly/4ejFQLQ #Healthcare #HealthcareInnovation #Pharma #Trending #Medtech #PharmaServices #BioTech #GlobalSupplyChain #HealthTechMarket

Navigating Europe's complex landscape can be daunting for US biotech and pharma companies looking to launch a new #orphandrug. With 27 countries, 24 languages, and a host of different cultures, healthcare systems, regulations, and reimbursement mechanisms to navigate, that reputation isn’t unreasonable. However, there are several approaches to simplify the process. Discover advantages and disadvantages of the three main options for biotechs entering the European market: 👉 Out-licensing 👉 Going solo 👉 Partnering Explore more at: https://lnkd.in/eP6VsGjD #RareDiseases #OrphanDrugs #MarketAccess #Biotech

Research and Regulatory Challenges in Health Innovation The complex challenges researchers, companies, and startups face are navigating regulatory requirements and overcoming research hurdles. These obstacles can delay innovation and hinder progress. At Maxeome, we specialize in streamlining the research process and offering expert support for regulatory compliance. From impactful research to expert consultants, we help our clients overcome barriers and accelerate their work towards innovations. If you’re attending the Global Health Exhibition (October 21-23), visit us to learn more about how Maxeome can support your projects and help you navigate these challenges. We look forward to discussing how we can drive healthcare innovation together. maxeome.com #GlobalHealthExhibition #Biotech #Startup #Consulting #HealthcareInnovation #Research #Medicine #Pharma #Science #SaudiArabia

At Anervea, our journey embarked from a singular, probing question: Why do #IndianPharma companies trail in harnessing the power of data? This question ignited our passion and fueled our mission. We've dedicated ourselves to pioneering the movement towards comprehensive data utilization within the pharmaceutical sector. As we navigate this path, the strides we've made have been both inspiring and transformative. Leading the charge to bridge this critical gap, the results we've witnessed are not just promising but revolutionary. Join us as we continue to innovate, excel, and redefine the future of healthcare through #DataScience, #Innovation, #HealthTech, and #DigitalTransformation. The journey is far from over; it's just the beginning. #AnerveaRevolution #LeadingChange #PharmaInnovation https://lnkd.in/d9CA42Fx

SYNTHIA is a new pioneering #public-private partnership for a 360º vision on advancing healthcare applications through SyntheticData use. SYNTHIA means: #SyntheticData generation framework for integrated validation of use cases and #AI #healthcare applications. It's about collaboration and innovation. By bringing together the brightest minds we aim to foster trust in #syntheticdata, build a dedicated federated platform, and pave the way for future breakthroughs in healthcare.  Please scan the quote of the SYNTHIA Project Lead Amied Shadmaan, GE HealthCare read more in our press release at www.ihi-synthia.eu This project is supported by the Innovative Health Initiative (IHI) (IHI JU) under grant agreement No 101172872. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA - European Federation of Pharmaceutical Industries and Associations, EuropaBio - the European Association for Bioindustries, MedTech Europe, and Vaccines Europe and DNV. #FutureOfMedicine #Datascience #EUInnovation #HealthResearch

Asset, brand, and competitive strategy Developing, implementing, and evolving strategic approaches to challenges in an ever-changing global healthcare environment requires deep understanding of your asset, your team, and the surrounding landscape. Our BRAVE process nurtures the development of carefully tailored workshops and solutions to ensure your vision becomes a reality. For more information about our approach, or to explore how we can help you, reach out to us at hello@onlythebrave.uk #BRAVEteam #BRAVElaunch #medcomms #pharma #biotech

At Sciensus, we excel in designing research protocols to capture real-world data, empowering biotech companies to make informed decisions throughout their orphan drug development lifecycle. Our comprehensive support spans: 👉 Clinical study design 👉 Funding submissions 👉 Market access initiatives 👉 Post-market studies 👉 Product evolution strategies Find out more here: https://lnkd.in/gVt-2y49 #RealWorldData #RareDiseases #PatientSupport #OrphanDrugs #PatientInsights #Biotech #Insights